Kamada Ltd. (TLV:KMDA)
Israel · Delayed Price · Currency is ILS · Price in ILA | Market Cap | 1.40B -6.2% |
| Revenue (ttm) | 575.31M +12.1% |
| Net Income | 64.39M +39.7% |
| EPS | 1.12 +40.0% |
| Shares Out | 57.69M |
| PE Ratio | 21.81 |
| Forward PE | 15.57 |
| Dividend | 0.74 (3.04%) |
| Ex-Dividend Date | Mar 23, 2026 |
| Volume | 29,861 |
| Average Volume | 55,622 |
| Open | 2,452.00 |
| Previous Close | 2,452.00 |
| Day's Range | 2,421.00 - 2,470.00 |
| 52-Week Range | 1,956.00 - 2,890.00 |
| Beta | 0.31 |
| RSI | 35.05 |
| Earnings Date | May 13, 2026 |
About Kamada
Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM f... [Read more]
Full Company ProfileFinancial Performance
In 2025, Kamada's revenue was $180.46 million, an increase of 12.12% compared to the previous year's $160.95 million. Earnings were $20.20 million, an increase of 39.66%.
Financial numbers in USD Financial StatementsNews
Significant Move: Lilach Payorski Invests $80K In Kamada Stock Options
Disclosed in a recent SEC filing, Lilach Payorski , Board Member at Kamada (NASDAQ: KMDA), made a strategic move by acquiring company stock options on April 9,. What Happened: Uncovered in a Form 4 f...
Eran Nir Sees Potential Growth And Acquires $178K In Kamada Stock Options
A noteworthy insider acquisition was disclosed on April 9, as Nir, VP at Kamada (NASDAQ: KMDA), reported the acquisition of stock options for 112,500 shares. What Happened: Nir, VP at Kamada, engaged...
David Tsur Takes A Bullish Stance, Acquiring $113K Worth Of Kamada Stock Options
A substantial insider move unfolded on April 9, as Tsur, Director at Kamada (NASDAQ: KMDA), reported the acquisition of stock options for 56,500 shares in an SEC filing. What Happened: Disclosed in a...
Ishay Davidi Expands Holdings With $113K Kamada Stock Options Acquisition
Ishay Davidi , Board Member at Kamada (NASDAQ: KMDA), reported acquisition of company stock options on April 9, according to a new SEC filing. What Happened: In a recent Form 4 filing with the U.S. S...
Chaime Orlev At Kamada Secures Company Stock Options: $417K Acquired
A substantial insider move unfolded on April 9, as Orlev, Chief Financial Officer at Kamada (NASDAQ: KMDA), reported the acquisition of stock options for 202,500 shares in an SEC filing. What Happene...
Nir Livneh Enhances Portfolio With Kamada Stock Options: $206K Acquired
In a new SEC filing on April 9, it was unveiled that Livneh, VP at Kamada (NASDAQ: KMDA), acquired stock options for 99,485 shares. What Happened: Livneh, VP at Kamada, engaged in a derivative transa...
Benjamin Dekel Takes A Bullish Stance, Acquiring Kamada Stock Options Worth $41K
In a recent SEC filing, it was disclosed that Benjamin Dekel, Director at Kamada (NASDAQ: KMDA), made a noteworthy acquisition of company stock options on April 9,. What Happened: Dekel, Director at ...
Leon Recanati Expands Holdings With $115K Kamada Stock Options Acquisition
A notable acquisition unfolded on April 9, as Recanati, Director at Kamada (NASDAQ: KMDA), reported the acquisition of stock options for 56,500 shares in an SEC filing. What Happened: Recanati, Direc...
Assaf Itshayek Sees Potential Growth And Acquires Kamada Stock Options Worth $41K
A noteworthy insider acquisition was disclosed on April 9, as Itshayek, Director at Kamada (NASDAQ: KMDA), reported the acquisition of stock options for 16,000 shares. What Happened: In a recent Form...
Hanni Neheman Backs Up Beliefs With A Notable $118K Acquisition In Kamada Stock Options
A notable acquisition unfolded on April 9, as Neheman, VP at Kamada (NASDAQ: KMDA), reported the acquisition of stock options for 75,000 shares in an SEC filing. What Happened: Disclosed in a Form 4 ...
Kamada (KMDA) Secures Favorable Tax Ruling on Cash Dividend
Kamada (KMDA) Secures Favorable Tax Ruling on Cash Dividend
Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas
REHOVOT, Israel and HOBOKEN, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ...
Kamada Ltd (KMDA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook
Kamada Ltd (KMDA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook
Q4 2025 Kamada Ltd Earnings Call Transcript
Q4 2025 Kamada Ltd Earnings Call Transcript
Kamada (KMDA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Kamada (KMDA) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Stree...
Kamada Shares Slip Despite Record FY25 Results And Dividend Declaration
(RTTNews) - Kamada Ltd. (KMDA) reported record top- and bottom-line results for 2025 and announced a cash dividend under its newly adopted annual policy.
Earnings Scheduled For March 11, 2026
Companies Reporting Before The Bell • Sprinklr (NYSE: CXM) is estimated to report quarterly earnings at $0.08 per share on revenue of $216.94 million. • Smith Douglas Homes (NYSE: SDHC) is projected...
Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth
REHOVOT, Israel, and HOBOKEN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for...
Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy
REHOVOT, Israel and HOBOKEN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.
What's Next: Kamada's Earnings Preview
Kamada (NASDAQ: KMDA) is gearing up to announce its quarterly earnings on Wednesday, 2026-03-11. Here's a quick overview of what investors should know before the release. Analysts are estimating that...
Earnings To Watch: Kamada Ltd (KMDA) Reports Q4 2025 Result
Earnings To Watch: Kamada Ltd (KMDA) Reports Q4 2025 Result
Ahead of Kamada (KMDA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Kamada (KMDA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quar...
Kamada (KMDA) Projects Strong Revenue and EBITDA Growth by 2026
Kamada (KMDA) Projects Strong Revenue and EBITDA Growth by 2026
Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender
REHOVOT, Israel, and HOBOKEN, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ...
Kamada Ltd Corporate Update Call Transcript
Kamada Ltd Corporate Update Call Transcript